CD4+ T Cell Defects in a Mulibrey Patient With Specific TRIM37 Mutations-Reference-Cited by-同舟云学术

CD4+ T Cell Defects in a Mulibrey Patient With Specific TRIM37 Mutations

Published:2020-09-18 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Bruzzaniti Sara,Cirillo Emilia,Prencipe Rosaria,Giardino Giuliana,Lepore Maria Teresa,Garziano Federica,Perna Francesco,Procaccini Claudio,Mascolo Luigi,Pagano Cristina,Fattorusso Valentina,Mozzillo Enza,Bifulco Maurizio,Matarese Giuseppe,Franzese Adriana,Pignata Claudio,Galgani Mario

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference31 articles.

1. Characterisation of the Mulibrey nanism-associated TRIM37 gene: transcription initiation, promoter region and alternative splicing;Hamalainen;Gene.,2006

2. TRIMming down to TRIM37: relevance to inflammation, cardiovascular disorders, and cancer in Mulibrey nanism;Brigant;Int J Mol Sci.,2018

3. New intragenic rearrangements in non-finnish Mulibrey nanism;Jobic;Am J Med Genet Part A.,2017

4. Mulibrey nanism: two novel mutations in a child identified by Array CGH and DNA sequencing;Mozzillo;Am J Med Genet Part A.,2016

5. Mulibrey nanism: clinical features and diagnostic criteria;Karlberg;J Med Genet.,2004

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mulibrey nanism and immunological complications: a comprehensive case report and literature review;Frontiers in Immunology;2023-12-05

2. Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape;Journal of Advanced Research;2023-12

3. TRIM11 attenuates Treg cell differentiation by p62-selective autophagic degradation of AIM2;Cell Reports;2023-10

4. The TRIM37 variants in Mulibrey nanism patients paralyze follicular helper T cell differentiation;Cell Discovery;2023-08-01

5. Comprehensive profiling of the TRIpartite motif family to identify pivot genes in hepatocellular carcinoma;Cancer Medicine;2022-02-09